Showing 6581-6590 of 10618 results for "".
- Cardiac Resynchronization Therapy in Elderly Heart Failure: Merging Device and Cardio-Metabolic Strategieshttps://reachmd.com/news/cardiac-resynchronization-therapy-in-elderly-heart-failure-merging-device-and-cardio-metabolic-strategies/2475023/Cardiac resynchronization therapy (CRT) is an established approach for managing elderly patients with heart failure, though a reluctance to combine devices and insufficient focus on cardiometabolic care may lead to less than optimal outcomes.
- Evolving Strategies to Prevent Cancer in Inflammatory Bowel Disease: Integrating Therapeutics and Surgeryhttps://reachmd.com/news/evolving-strategies-to-prevent-cancer-in-inflammatory-bowel-disease-integrating-therapeutics-and-surgery/2474985/In inflammatory bowel disease, persistent mucosal injury in ulcerative colitis and Crohn's disease poses a significant cancer risk, yet many clinicians grapple with controlling chronic low-grade inflammation before dysplasia emerges. C
- Bridging Gaps in Minimally Invasive Surgery: Overcoming Underutilization and Elevating Outcomeshttps://reachmd.com/news/bridging-gaps-in-minimally-invasive-surgery-overcoming-underutilization-and-elevating-outcomes/2474915/Despite evidence showing faster recovery, laparoscopic repair of perforated gastroduodenal ulcers is underutilized, even as antireflux procedures set new standards for postoperative quality of life. Real-world data from
- Aerobic Exercise and Non-Surgical Management of Knee Osteoarthritishttps://reachmd.com/news/aerobic-exercise-and-non-surgical-management-of-knee-osteoarthritis/2474933/Recent data on the impact of aerobic exercises on knee osteoarthritis outcomes demonstrates that structured walking, cycling, and swimming regimens can significantly r
- FDA Approves Zoryve Foam: A Game-Changer for Plaque Psoriasishttps://reachmd.com/news/fda-approves-zoryve-foam-a-game-changer-for-plaque-psoriasis/2474924/Amid persistent challenges with cumbersome ointments and poor adherence in plaque psoriasis, dermatologists now have a new option: the FDA approval of Zoryve topical foam for scalp and body lesions in patients aged 12 and older. For cl
- ADA: Dermatologists Need to Lead on Climate Healthhttps://reachmd.com/news/ada-dermatologists-need-to-lead-on-climate-health/2474867/The American Dermatological Association (ADA) has issued its first comprehensive policy statement on climate change, publishing the document in the Journal of Investigative Dermatology.
- Navigating the Shift to Non-Opioid Pain Management in Surgeryhttps://reachmd.com/news/navigating-the-shift-to-non-opioid-pain-management-in-surgery/2474902/Clinicians are confronting a pivotal dilemma: achieving robust analgesia for acute and perioperative pain while mitigating the well-documented hazards of opioid exposure. Breakthroughs in non-opioid pharmacotherapy may offer a solution
- AI-Enhanced 3D Virtual Staining: The Future of Non-Invasive Cancer Diagnosticshttps://reachmd.com/news/ai-enhanced-3d-virtual-staining-the-future-of-non-invasive-cancer-diagnostics/2474860/Rapid advances in AI-enhanced imaging are redefining cancer diagnostics, and 3D virtual staining offers clinicians detailed insights into tumor biology. However, it is important to acknowledge that the technology is still undergoing validatio
- Cutaneous Immune-Related Adverse Events: Indicators of Systemic Toxicities and Survival in Melanomahttps://reachmd.com/news/cutaneous-immune-related-adverse-events-indicators-of-systemic-toxicities-and-survival-in-melanoma/2474813/Cutaneous immune-related adverse events (cIRAEs) in melanoma patients undergoing immune checkpoint inhibitor therapy present a clinical paradox. While these skin toxicities indicate an increased risk of multisystem adverse events—including gastrointestinal, ocular, endocrin
- Depression and Its Role in Predicting Future Physical Painhttps://reachmd.com/news/depression-and-its-role-in-predicting-future-physical-pain/2474800/Recent research confirms that depressive symptoms can serve as precursors to physical pain. A longitudinal study of individuals in their middle and later years indicates those experiencing increasing depression up to eight years before the onset of pai